HEMOTYPESC IS NOW REGISTERED IN GHANA, NIGERIA, KENYA & INDIA

AN IMPORTANT PROBLEM: A DEADLY DISEASE

More than 5% of the world’s population are healthy carriers of a gene for sickle-cell disease.

In some regions, over 25% of people are carriers.

Every year more than 5 million children are born with sickle cell trait, and over 400,000 are born with sickle cell disease.

Newborn screening is not widespread in low-resource regions and sickle cell disease has up to 80% childhood mortality, without proper treatment.

Newborn screening followed up with available, inexpensive treatment significantly reduces sickle cell disease mortality.

A UNIVERSAL SOLUTION: NEWBORN SCREENING FOR HEMOGLOBIN TYPE

HemoTypeSC™ is a rapid test kit for the determination of hemoglobin type in whole blood.

This test provides point-of-care detection of hemoglobin phenotypes HbAA (normal), HbSS and HbSC (sickle cell disease), HbCC (hemoglobin C disease), and HbAS and HbAC (carrier or trait).

Fast

Using about one microliter of whole blood, results are available at the point-of-care in about ten minutes.

Portable

Testing can be performed in virtually any location. HemoTypeSC™ does not require instrumentation, electricity, refrigeration, or extensive training. It is simple to use and appropriate for screening individuals in rural and low-resource settings.

Accurate

Preliminary data indicates that HemoTypeSC™ has shown 100% clinical accuracy in validation studies involving thousands of patients throughout Africa, India, and the Caribbean. Please contact us for more details.

RESULTS IN THE PALM OF YOUR HAND

FEATURES

  • Highly specific and ultra-sensitive monoclonal antibodies for hemoglobins A, S, and C
  • No interference from fetal hemoglobin
  • Test strip dimensions: 4mm x 75mm
  • No liquid buffer components and no refrigeration required
  • Stable in high heat
  • Overall sensitivity and specificity >99%, with 100% accuracy for detecting sickle cell anemia, in low-resource (Am J Hematol, 2018) and laboratory settings (Br J Haematol, 2016)

SUCCESS STORIES

In January, 2018, HemoTypeSC™ was utilized at Holy Family Hospital in Techiman, Ghana to screen over 400 newborns, infants, children, and adults for hemoglobins A, S, and C. This two-minute video tells the story.

TESTIMONIALS

Healthcare professionals using HemoTypeSC™ describe the positive outcomes for patients in clinics and hospitals around the world.